Tenaya Therapeutics (TNYA) Interest Expenses (2020 - 2026)

Tenaya Therapeutics' Interest Expenses history runs 7 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• On a quarterly basis, Interest Expenses rose 107.48% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $2.1 million, a 58.17% decrease from a year earlier, with the FY2025 full-year figure at $146.1 million, up 15.67% from the prior year.
• Interest Expenses improved to $2.1 million in Q1 2026 per TNYA's latest filing, from $947000.0 in the prior quarter.
• Across five years, Interest Expenses topped out at $22.5 million in Q2 2022 and bottomed at $4000.0 in Q4 2022.
• The 5-year median for Interest Expenses is $4.1 million (2023), against an average of $9.5 million.
• Across the five-year window, Interest Expenses tumbled 99.76% in 2022 and jumped 33575.0% in 2023, its largest moves.
• Year by year, Interest Expenses stood at $4000.0 in 2022, then soared by 33575.0% to $1.3 million in 2023, then slipped by 8.09% to $1.2 million in 2024, then decreased by 23.51% to $947000.0 in 2025, then surged by 116.68% to $2.1 million in 2026.
• Per Business Quant, the three latest TNYA Interest Expenses figures stand at $2.1 million (Q1 2026), $947000.0 (Q4 2025), and $14.1 million (Q3 2025).